"Stock picking marvel--or just a slick promoter" (Finance, Sept. 27) said a judge found that Rafi M. Kahn had "committed willful perjury." On Aug. 26, a U.S. appeals court vacated an injunction blocking his attempt to unseat the board of ICN Pharmaceuticals Inc. It also vacated the perjury finding, ruling "unless perjury is at issue in a case, such a finding is not necessary." The court declined to reverse the perjury finding, saying, "we perceive no basis for doing so on this record."
Before it's here, it's on the Bloomberg Terminal. LEARN MORE